Levitasbio, Inc.
Menlo Park, CA
- UEI
- V6K2TYFJ9Q31
- CAGE
- 81JY4
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1505 Adams Dr d, Menlo Park, CA 94025, USA
- Website
- levitasbio.com
- Founded
- 2017
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $15,500 |
| FY2024 | $25,000 |
| FY2023 | $90,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Levitasbio, Inc. is a for-profit corporate entity based in Menlo Park, California, specializing in the manufacture of advanced biomedical research equipment and reagents. Registered in SAM.gov since January 2018 and set to expire in January 2026, the company is certified as a Disadvantaged Business Enterprise (DBE) and focuses on producing sophisticated scientific instruments for medical research. While limited public information is available about the company's full background, its federal contract history demonstrates a strong focus on providing specialized equipment to various National Institutes of Health (NIH) divisions.
The company has secured multiple federal contract awards totaling approximately $223,240 across six purchase orders from different NIH agencies, including the National Human Genome Research Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Heart Lung and Blood Institute, NIH Clinical Center, and Headquarters Division. Levitasbio, Inc. primarily provides LEVICELL systems, COVID-19 research reagents, and related scientific equipment. These contracts have been predominantly focused on supporting medical research initiatives, particularly related to COVID-19 studies. Each contract has been a firm fixed-price purchase order with no specific set-aside designations, ranging from $15,500 to $90,000. The contracts typically involve delivering specialized biomedical research equipment like the LEVICELL-1.0 system, LEVI CELL EOS SYSTEM, and reagents needed for patient sample processing, with performance periods typically spanning one to two years.
Quick answers
Is Levitasbio, Inc. registered in SAM.gov?
Yes. Levitasbio, Inc.'s SAM.gov registration is active through December 19, 2026.
How much has Levitasbio, Inc. received in federal contracts?
Federal contracts obligated $15,500 to Levitasbio, Inc. in fiscal year 2025 and $130,500 in fiscal years 2023 through 2027.
How does Levitasbio, Inc. rank among federal contractors?
Levitasbio, Inc. ranked #94 in PSC J074 in FY2025.
What is Levitasbio, Inc.'s most recent federal award?
Levitasbio, Inc.'s most recent federal contract award is Levitasbio, INC.:1360186 [25-002006] (75N92E25P00156), from National Human Genome Research Institute (NIH), on May 5, 2025.
On GovTribe
See Levitasbio, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors